Searched over 200M research papers for "fatty heart"
10 papers analyzed
These studies suggest that fatty heart is a common and potentially fatal condition that can be identified early through noninvasive screening, with various factors such as fatty acid metabolism, dietary intake, and myocardial fat content playing significant roles in its development and impact on heart health.
20 papers analyzed
Fatty heart disease, also known as lipotoxic cardiomyopathy, is a condition characterized by the abnormal accumulation of fat within the heart muscle. This condition, once widely recognized, has seen a resurgence in interest due to its association with obesity and metabolic disorders.
Historically, fatty heart was a well-accepted clinical diagnosis. However, over the past few decades, its existence was questioned despite the rising prevalence of obesity and related cardiac abnormalities. Recent advancements, such as magnetic resonance spectroscopy, have enabled noninvasive screening, revealing that fat accumulation in cardiomyocytes correlates strongly with body mass index (BMI) and is exacerbated by conditions like diabetes.
Fatty heart can manifest in two primary forms: fatty infiltration and fatty degeneration. Fatty infiltration involves the accumulation of fat in the subepicardial connective tissue and between muscle fibers, while fatty degeneration refers to fat accumulation within the cardiomyocytes themselves. Both forms can lead to compromised cardiac function, with fatty infiltration particularly linked to sudden cardiac death and myocardial infarction.
The heart primarily relies on fatty acids for energy through beta-oxidation. However, in conditions like obesity and diabetes, excessive fatty acid uptake and oxidation can impair cardiac function. This metabolic overload can lead to the accumulation of toxic lipid species, contributing to cardiac damage and dysfunction.
Patients with fatty heart often present with symptoms of general debility, including fatigue, somnolence, and shortness of breath on exertion. Physical signs may include a small, feeble pulse and low blood pressure. These symptoms are indicative of the heart's reduced ability to pump effectively due to fat accumulation.
Modern diagnostic techniques, such as magnetic resonance spectroscopy, have made it possible to quantify myocardial fat content accurately. This method has shown that increased myocardial triglyceride stores are associated with obesity, impaired glucose tolerance, and type 2 diabetes .
Preventing fatty heart disease involves lifestyle changes that reduce caloric intake and increase fatty acid oxidation. Regular physical activity and a balanced diet can significantly lower the risk of fat accumulation in the heart.
Pharmacologic treatments that enhance fatty acid oxidation and improve glucose metabolism can also be effective. These interventions aim to reduce the metabolic burden on the heart and prevent the progression of fatty heart disease .
Fatty heart disease is a significant but often overlooked condition linked to obesity and metabolic disorders. Understanding its pathophysiology, clinical manifestations, and diagnostic techniques is crucial for early intervention and prevention. Lifestyle modifications and targeted pharmacologic treatments offer promising avenues for managing this condition and improving cardiac health.
Most relevant research papers on this topic